Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X about a recent article by Yu Yang et al., published in Annals of Internal Medicine, adding:
“Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis
DOACs were associated with an increased 1-year risk for stroke but a decreased risk for MI compared with warfarin.”
Title: Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis: A Target Trial Emulation
Authors: Yu Yang, Chin-Yao Shen, Michael Chun-Yuan Cheng, Wei Kang, Philip C. M. Au, Vincent K. C. Yan, Huei-Kai Huang, Chun Ka Wong, Kai Hang Yiu, Hung-Fat Tse, Ching-Lung Cheung, Timothy H. Rainer, Bryan P. Yan, David C. W. Siu, Ian Chi Kei Wong, Edward Chia-Cheng Lai, Esther W. Y. Chan
Other posts featuring Ahmed Bennis on Hemostasis Today.
-
Sep 30, 2026, 21:50Jagat Narula: Connecting Cardiovascular Health and Sickle Cell Disease on World Heart Day 2026
-
Sep 30, 2026, 21:38John Kastelein: Exploring the Biology of Cardiovascular Disease at BioCentury Grand Rounds Europe
-
Sep 30, 2026, 21:36Mark Murphy: Irish Heart Foundation Meets With Senator Teresa Costello on World Heart Day
-
Sep 30, 2026, 21:34Sadashiva Pai: How Pancreatic Cancer Uses Blood Clotting to Evade Immune Attack
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care